Atlas Trials

Efficacy and Safety of Lubiprostone in Patients With Irritable Bowel Syndrome With Constipation

Clinical trial NCT00380250 · COMPLETED

Trial details

NCT number
NCT00380250
Sponsor
Sucampo Pharma Americas, LLC
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Irritable Bowel Syndrome With Constipation
Start date
2005-05-01
Enrollment
590

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.